Insights

In Part I of his video, Dr. Ragy Girgis highlights the D3 receptor as a promising target in schizophrenia, with potential to address negative and cognitive symptoms unmet by...

In Part II of his video, Dr. Ragy Girgis examines D3 receptor binding by antipsychotics and its potential to improve negative symptoms in schizophrenia.

In this video, Dr. Kantrowitz provides an in-depth update on current and emerging treatments for the negative symptoms of schizophrenia. He discusses symptom classifications, key clinical trials, and potential...

In this video, Dr. Kantrowitz explores the potential of muscarinic acetylcholine receptor (mACHR) agonists and modulators for schizophrenia treatment, with a focus on M1 and M4 receptors. He reviews...

In this video, Dr. Correll discusses the role of the muscarinic receptor system in schizophrenia, exploring its impact on cognitive and functional outcomes. He examines the potential for targeting...

In this video, Dr. Correll examines the therapeutic potential of the muscarinic receptor system in schizophrenia treatment. He discusses how targeting muscarinic receptors may address cognitive and functional impairments,...